Proxeon and Bruker Daltonik Announce OEM Agreement

Bruker Daltonik to Offer Proxeon’s EASY-nLC, a Nanoscale Chromatography System, as Part of their LC/MS Product Portfolio Odense, Denmark and Bremen, Germany- November 15th, 2007- Proxeon A/S and Bruker Daltonik GmbH today announced that the companies have entered into an OEM agreement. Under the agreement, Bruker Daltonik will sell Proxeon’s nanoscale chromatography system, EASY-nLC™, together with their well-established range of products for mass (...)

Bruker BioSciences Reports Financial Results for the Third Quarter of 2007

BILLERICA, Mass., Oct 29, 2007 (BUSINESS WIRE) -- Bruker BioSciences Corporation (NASDAQ: BRKR) today reported its financial results for the three and nine months ended September 30, 2007. For the third quarter of 2007, revenue increased by 25% to $131.6 million, compared to revenue of $104.9 million in the third quarter of 2006. Excluding the effects of foreign currency translation, third quarter 2007 revenue increased by 20% year-over-year. Net income (...)

Bruker BioSciences Corporation to Release Third Quarter 2007 Financial Results on October 29, 2007

BILLERICA, Mass.--(BUSINESS WIRE)--Oct. 25, 2007--Bruker BioSciences Corporation (NASDAQ:BRKR) plans to release its third quarter 2007 financial results on Monday, October 29, 2007 before the market opens. Bruker BioSciences will then host an operator-assisted earnings conference call that morning at 10 a.m. Eastern Time. To listen to the webcast, investors can go to www.bruker-biosciences.com and click on the live web broadcast symbol. The webcast will (...)

Bruker Companies Announce the Opening of a Modern Chinese Applications, Demonstration and Customer Training Center in Beijing

Bruker Companies Announce the Opening of a Modern Chinese Applications, Demonstration and Customer Training Center in BeijingBEIJING--(BUSINESS WIRE)--Oct. 18, 2007--During the BCEIA 2007 conference, Bruker BioSciences Corp. and the Bruker BioSpin group of companies today announced the official opening of their new Beijing modern applications, demonstration and customer training laboratory, showcasing a wide selection of novel life science and materials (...)

Bruker Daltonics Introduces Several Important and Novel Proteomics Capabilities and Solutions at HUPO 2007

SEOUL, South Korea, Oct 07, 2007 (BUSINESS WIRE) -- At the Human Proteome Organisation's (HUPO) 6th Annual World Congress, Bruker Daltonics is announcing several novel capabilities and solutions for proteomics mass spectrometry at two Bruker luncheon seminars on Monday and Wednesday, as well as in more than 40 scientific oral and poster contributions.

Bruker Daltonics was the first company to introduce ETD (Electron Transfer Dissociation) on its (...)

Bruker BioSciences to Present at UBS Global Life Sciences Conference

Live Webcast on September 26th at 9:00 AM Eastern Time from New York

BILLERICA, Mass.--(BUSINESS WIRE)--Sept. 24, 2007--Bruker BioSciences Corporation today announces that it will join other leading healthcare and life sciences companies in presenting at the UBS Global Life Sciences Conference taking place in New York. The Company will present an update on recent developments and expectations.

The presentation will be webcast live at 9:00 AM Eastern (...)

Bruker Daltonics Announces Contract Award for Phase III of the ARFCAM Program by the U.S. Department of Homeland Security

BILLERICA, Mass.--(BUSINESS WIRE)--Sept. 14, 2007--Bruker Daltonics today announces that it has been awarded a $1.3 million follow-on Phase III contract for further research, development and testing within the Autonomous Rapid Facility Chemical Agent Monitor (ARFCAM) program by the U.S. Department of Homeland Security (DHS). This Phase III program is expected to last about three years during which time Bruker will continue to even further improve its (...)

Bruker BioSciences to Present at Bear Stearns 20th Annual Healthcare Conference

Live Webcast on September 10th at 9:30 AM Eastern Time from New York

BILLERICA, Mass.--(BUSINESS WIRE)--Sept. 7, 2007--Bruker BioSciences Corporation today announces that it will join other leading healthcare and life sciences companies in presenting at the Bear Stearns 20th Annual Healthcare Conference taking place September 10th and 11th in New York. Bruker BioSciences President and CEO Frank Laukien will present an overview of the Company, including (...)